13FACADIA PHARMACEUTICALS INC (ACAD)
6 tracked managers currently hold ACAD on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | Q2 2026 | TRIM | $61.6M | 0.1 % | 0.1 % | 2,433,168 | -144,748 |
| CITADEL ADVISORS LLC | Q2 2026 | ADD | $55.2M | 0.0 % | 0.0 % | 2,182,177 | +1,559,417 |
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $43.0M | 0.0 % | 0.0 % | 1,697,937 | +968,101 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | ADD | $23.5M | 0.0 % | 0.0 % | 926,992 | +151,871 |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | TRIM | $14.9M | 0.0 % | 0.0 % | 589,924 | -115,537 |
| Bridgewater Associates, LP | Q2 2026 | TRIM | $1.3M | 0.0 % | 0.0 % | 50,265 | -91,547 |